NO122840B - - Google Patents
Download PDFInfo
- Publication number
- NO122840B NO122840B NO0591/69A NO59169A NO122840B NO 122840 B NO122840 B NO 122840B NO 0591/69 A NO0591/69 A NO 0591/69A NO 59169 A NO59169 A NO 59169A NO 122840 B NO122840 B NO 122840B
- Authority
- NO
- Norway
- Prior art keywords
- methoxy
- methyl
- groups
- methanol
- compound
- Prior art date
Links
- -1 1-amino-1-methyl-ethyl group Chemical group 0.000 claims description 29
- 150000001875 compounds Chemical class 0.000 claims description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 12
- 125000004423 acyloxy group Chemical group 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000007858 starting material Substances 0.000 claims description 9
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical class NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 102
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 42
- 230000002829 reductive effect Effects 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 18
- 239000000155 melt Substances 0.000 description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 15
- 239000011541 reaction mixture Substances 0.000 description 15
- 238000001953 recrystallisation Methods 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 13
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- 238000009835 boiling Methods 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
- 239000001257 hydrogen Substances 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000012442 inert solvent Substances 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 239000007868 Raney catalyst Substances 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- 230000036571 hydration Effects 0.000 description 5
- 238000006703 hydration reaction Methods 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- KJVQAFGRJZVLSE-UHFFFAOYSA-N 1-[4-methoxy-3,5-bis(phenylmethoxy)phenyl]propan-2-one Chemical compound C(C1=CC=CC=C1)OC=1C=C(C=C(C1OC)OCC1=CC=CC=C1)CC(C)=O KJVQAFGRJZVLSE-UHFFFAOYSA-N 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 4
- 239000005695 Ammonium acetate Substances 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 235000019257 ammonium acetate Nutrition 0.000 description 4
- 229940043376 ammonium acetate Drugs 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000007327 hydrogenolysis reaction Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052987 metal hydride Inorganic materials 0.000 description 3
- 150000004681 metal hydrides Chemical class 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- WAOQJWSTWQZQQU-UHFFFAOYSA-N 4-methoxy-3,5-bis(phenylmethoxy)benzaldehyde Chemical compound C1=C(C=O)C=C(OCC=2C=CC=CC=2)C(OC)=C1OCC1=CC=CC=C1 WAOQJWSTWQZQQU-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- IXIGGVUBAKPQKF-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)OC=1C=C(C(=O)Cl)C=C(C1OC)OC(C1=CC=CC=C1)=O Chemical compound C(C1=CC=CC=C1)(=O)OC=1C=C(C(=O)Cl)C=C(C1OC)OC(C1=CC=CC=C1)=O IXIGGVUBAKPQKF-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000012448 Lithium borohydride Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 150000003935 benzaldehydes Chemical class 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- LYGJENNIWJXYER-BJUDXGSMSA-N nitromethane Chemical class [11CH3][N+]([O-])=O LYGJENNIWJXYER-BJUDXGSMSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- NQCUJDRCDRQVFM-UHFFFAOYSA-N (3-benzoyloxy-5-formyl-2-methoxyphenyl) benzoate Chemical compound C(C1=CC=CC=C1)(=O)OC=1C=C(C=O)C=C(C1OC)OC(C1=CC=CC=C1)=O NQCUJDRCDRQVFM-UHFFFAOYSA-N 0.000 description 1
- JSZOAYXJRCEYSX-UHFFFAOYSA-N 1-nitropropane Chemical compound CCC[N+]([O-])=O JSZOAYXJRCEYSX-UHFFFAOYSA-N 0.000 description 1
- ABEPSQZVZNRXCY-UHFFFAOYSA-N 3,4,5-tris(phenylmethoxy)benzaldehyde Chemical compound C=1C=CC=CC=1COC=1C(OCC=2C=CC=CC=2)=CC(C=O)=CC=1OCC1=CC=CC=C1 ABEPSQZVZNRXCY-UHFFFAOYSA-N 0.000 description 1
- YWHSFCHIFAUGJV-UHFFFAOYSA-N 3,5-dibenzoyloxy-4-methoxybenzoic acid Chemical compound C(C1=CC=CC=C1)(=O)OC=1C=C(C(=O)O)C=C(C1OC)OC(C1=CC=CC=C1)=O YWHSFCHIFAUGJV-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- FWNNQQDQXAMXMK-UHFFFAOYSA-N 5-(2-aminopropyl)benzene-1,2,4-triol Chemical compound CC(N)CC1=CC(O)=C(O)C=C1O FWNNQQDQXAMXMK-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JZUPJXIHBOOZIM-UHFFFAOYSA-N [3-benzoyloxy-2-methoxy-5-(2-oxopropyl)phenyl] benzoate Chemical compound C(C1=CC=CC=C1)(=O)OC=1C=C(C=C(C1OC)OC(C1=CC=CC=C1)=O)CC(C)=O JZUPJXIHBOOZIM-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- ZDKRMIJRCHPKLW-UHFFFAOYSA-N benzyl methanesulfonate Chemical class CS(=O)(=O)OCC1=CC=CC=C1 ZDKRMIJRCHPKLW-UHFFFAOYSA-N 0.000 description 1
- 150000005524 benzylchlorides Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical class OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- LLCOIQRNSJBFSN-UHFFFAOYSA-N methane;sulfurochloridic acid Chemical compound C.OS(Cl)(=O)=O LLCOIQRNSJBFSN-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940048346 phenethylamine hydrochloride Drugs 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- BBDNZMUIQBRBJH-UHFFFAOYSA-N sulfurochloridic acid;toluene Chemical compound OS(Cl)(=O)=O.CC1=CC=CC=C1 BBDNZMUIQBRBJH-UHFFFAOYSA-N 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Analogifremgangsmåte for fremstilling av terapeutisk Analogy method for the preparation of therapeutic
virksomme fenetylaminderivater. active phenethylamine derivatives.
Nærværende oppfinnelse vedrorer en fremgangsmåte for fremstilling av terapeutisk virksomme fenetylaminderivater med den generelle formel hvor og R2 betyr hydroksy eller lavere alkoksy og The present invention relates to a method for the production of therapeutically effective phenethylamine derivatives with the general formula where and R2 means hydroxy or lower alkoxy and
R^ lavere alkyl, R^ lower alkyl,
såvel som salter av disse forbindelser. as well as salts of these compounds.
De foran nevnte alkoksyrester kan inneholde inntil 6 karbonatomer, som f.eks. metoksy- eller etoksy-resten. Også»de lavere alkylrester inneholder inntil 6 karbonatomer. Alkylrest-ene kan være forgrenet eller uforgrenet. Som eksempler på lavere alkylrester kan nevnes metyl-, etyl- eller isopropyl-resten. The above-mentioned carboxylic acid residues can contain up to 6 carbon atoms, which e.g. the methoxy or ethoxy residue. Also» the lower alkyl residues contain up to 6 carbon atoms. The alkyl radicals can be branched or unbranched. As examples of lower alkyl residues, the methyl, ethyl or isopropyl residue can be mentioned.
Som representative representanter av de ifolge oppfinnelsen fremstillbare forbindelser med formel I kan blant annet nevnes: 3,5-dihydroksy-4-metoksy-a-metyl-fenetylamin, smp. 222 - 224°C, 3.4- dihydroksy-5-metoksy-a-metyl-fenetylamin, smp. 270 - 272°C, 3 , 4, 5-trihydrolcsy-ct-metyl-f enetylamin, smeltepunkt ikke målbart, 3.5- dihydroksy-4-metoksy-a-etyl-fenetylamin, smp. 160 - 163°C. Fenetylaminderivatene med den generelle formel I og deres salter fremstilles ifolge oppfinnelsen ved at man hydrogenolyserer en forbindelse med den generelle formel hvor X ^betegner en av gruppene As representative representatives of the compounds of formula I which can be prepared according to the invention, the following can be mentioned, among others: 3,5-dihydroxy-4-methoxy-a-methyl-phenethylamine, m.p. 222 - 224°C, 3,4-dihydroxy-5-methoxy-α-methyl-phenethylamine, m.p. 270 - 272°C, 3, 4, 5-trihydrolcsy-ct-methyl-phenethylamine, melting point not measurable, 3.5-dihydroxy-4-methoxy-α-ethyl-phenethylamine, m.p. 160 - 163°C. The phenethylamine derivatives with the general formula I and their salts are prepared according to the invention by hydrogenolyzing a compound with the general formula where X ^denotes one of the groups
og , R2 og R^ har foran angitte betydning, and , R2 and R^ have the above meaning,
idet frie hydroksylgrupper er erstattet med aralk- in that free hydroxyl groups are replaced with aralk-
oksygrupper, oxygen groups,
eller at man hydrolyserer en forbindelse med den generelle formel II, or that one hydrolyzes a compound of the general formula II,
hvor X betegner gruppen where X denotes the group
og and
R^ , R£ og R^ har foran angitte betydning, idet frie R^ , R£ and R^ have the meaning given above, being free
hydroksylgrupper er erstattet med acyloksygrupper, og at man, hvis onsket, overforer den erholdte forbindelse med formel I til et salt. hydroxyl groups are replaced by acyloxy groups, and that, if desired, the obtained compound of formula I is converted to a salt.
Frie hydroksygrupper i forbindelser med formel II er beskyttet med acylrester, spesielt med lavere alkanoylrester, som f.eks. acetyl- eller aroylrester, som f.eks. benzoylrester eller med aralkylrester fortrinnsvis med aryl-laverealkylrester, som f.eks. benzylrester. Free hydroxy groups in compounds of formula II are protected with acyl residues, especially with lower alkanoyl residues, such as e.g. acetyl or aroyl residues, such as benzoyl residues or with aralkyl residues, preferably with aryl-lower alkyl residues, such as e.g. benzyl residues.
De som utgangssubstanser anvendte forbindelser med den gene- The compounds used as starting substances with the gene
relle formel II, hvor X er resten relle formula II, where X is the residue
kan fremstilles på i og for seg kjent måte f.eks. ved at man overforer et tilsvarende ringsubstituert benzaldehyd, i hvilket frie hydroksylgrupper er erstattet med acyloksy- eller aralkyloksygrupper, ved behandling med et alkylsubstituert nitrometan i nærvær av et amin, fortrinnsvis n-butylamin eller benzylamin eller et ammoniumsalt, spesielt ammoniumacetat, i et mellom ca. 20 og 120°C liggende temperaturområde til det tilsvarende ringsubstituerte (3-nitro-(3-alkyl-styrol, og reduserer dette ved hjelp av et komplekst metallhydrid, fortrinnsvis ved hjelp av litiumaluminiumhydrid i et inert opplosningsmiddel, som f.eks. eter eller tetrahydrofuran i et mellom ca. værelsetemperatur og kokepunktet for oppldsningsmidlet liggende temperaturområde. Den samme utgangsforbindelse med formel II kan videre f.eks. fremstilles ved at man overforer på i og for seg kjent måte en tilsvarende ringsubstituert benzosyreester eller en substi-tuert benzosyre, i hvilken frie hydroksygrupper er erstattet med acyloksy- eller aralkyloksygrupper, ved halogenering til det tilsvarende benzoylhalogenid, reduserer dette ved hjelp av et komplekst metallhydrid, f.eks. ved hjelp av litiumaluminiumhydrid, natriumborhydrid eller også med diboran i et inert opplosningsmiddel som eter, dioksan/vann eller dietylenglykol-dimetyleter i et mellom 0 og 40°C liggende temperaturområde, omsetter den dannede alkohol med et halogeneringsmiddel, f.eks. med fosfortriklorid eller tionylklorid i et inert opplosningsmiddel som eter, benzen eller metylenklorid, eller et alkalisalt av denne alkohol med et sulfoneringsmiddel, f.eks. med metansulfoklorid eller toluensulfoklorid i et mellom værelsetemperatur og koketemperaturen for reaksjonsblandingen liggende temperaturområde til et ringsubstituert benzylklorid eller -mesylat eller -tosylat. Deretter omsettes det erholdte halo-genid henh. sulfonat på vanlig måte med et alkalisalt av en alkylsubstituert malonsyreester i et inert opplosningsmiddel, f.eks. i en alkanol eller i benzen, spesielt i dimetylformamid i et mellom ca. 20 og 100°C liggende temperaturområde. Den erholdte ester kan f.eks. forsåpes ved behandling med alkoholisk vandig alkali, fortrinnsvis ved innvirkning, av kaliumhydroksyd i metanol/vann ved veer els etemperatur. Den dannede dikarboksyl-syre kan f.eks. selektivt dekarboksyleres ved oppvarmning, fortrinnsvis ved oppvarmning i nærvær av en fortynnet mineralsyre, f.eks. i 2-n svovelsyre. can be produced in a manner known per se, e.g. by transferring a corresponding ring-substituted benzaldehyde, in which free hydroxyl groups have been replaced by acyloxy or aralkyloxy groups, by treatment with an alkyl-substituted nitromethane in the presence of an amine, preferably n-butylamine or benzylamine or an ammonium salt, especially ammonium acetate, in a between approx. . 20 and 120°C lying temperature range to the corresponding ring-substituted (3-nitro-(3-alkyl-styrene), and reduces this with the help of a complex metal hydride, preferably with the help of lithium aluminum hydride in an inert solvent, such as ether or tetrahydrofuran in a temperature range between approx. in which free hydroxy groups are replaced by acyloxy or aralkyloxy groups, by halogenation to the corresponding benzoyl halide, this is reduced with the help of a complex metal hydride, for example with the help of lithium aluminum hydride, sodium borohydride or also with diborane in an inert solvent such as ether, dioxane/ water or diethylene glycol dimethyl ether in a temperature range between 0 and 40°C, it reacts d other alcohol with a halogenating agent, e.g. with phosphorus trichloride or thionyl chloride in an inert solvent such as ether, benzene or methylene chloride, or an alkali salt of this alcohol with a sulphonating agent, e.g. with methanesulfochloride or toluenesulfochloride in a temperature range between room temperature and the boiling temperature of the reaction mixture to a ring-substituted benzyl chloride or -mesylate or -tosylate. The resulting halogenide is then reacted according to sulphonate in the usual way with an alkali salt of an alkyl substituted malonic acid ester in an inert solvent, e.g. in an alkanol or in benzene, especially in dimethylformamide in a between approx. 20 and 100°C horizontal temperature range. The obtained ester can e.g. is saponified by treatment with alcoholic aqueous alkali, preferably by the action of potassium hydroxide in methanol/water at veer or e temperature. The formed dicarboxylic acid can e.g. is selectively decarboxylated by heating, preferably by heating in the presence of a dilute mineral acid, e.g. in 2-n sulfuric acid.
Det dannede oc-alkyl-substituerte fenylpropionsyrederivat kan f.eks. omsettes ved behandling med en klormaursyreester eller også ved behandling med tionylklorid, fosforoksyklorid eller fosforpentaklorid til det tilsvarende blandete anhydrid, deretter overfores ved behandling med natriumazid i et inert opplosningsmiddel, som f.eks. aceton mellom 0 og 30°C til azidet og ved oppvarmning omdannes til det tilsvarende isocyanat, som igjen ved innvirkning av fortynnet vandig mineralsyre gir den dnskede utgangsforbindelse med formel II, hvor X er resten The oc-alkyl-substituted phenylpropionic acid derivative formed can e.g. is converted by treatment with a chloroformic acid ester or also by treatment with thionyl chloride, phosphorus oxychloride or phosphorus pentachloride to the corresponding mixed anhydride, then transferred by treatment with sodium azide in an inert solvent, such as e.g. acetone between 0 and 30°C to the azide and on heating is converted to the corresponding isocyanate, which again under the influence of dilute aqueous mineral acid gives the desired starting compound of formula II, where X is the residue
De som utgangssubstanser anvendte forbindelser med den generelle formel II, hvor X er en 2-imino-2-alky1-etyl-gruppe, kan fremstilles på i og for seg kjent måte f.eks. ved at man til-setter et tilsvarende ringsubs tituert (3-nitro-(3-alkyl-styrol, The compounds of the general formula II used as starting substances, where X is a 2-imino-2-alkyl-ethyl group, can be prepared in a manner known per se, e.g. by adding a corresponding ring substituted (3-nitro-(3-alkyl-styrene,
i hvilket frie hydroksylgrupper er erstattet med acyloksy- eller aralkyloksygrupper, til en til koking oppvarmet blanding av in which free hydroxyl groups are replaced by acyloxy or aralkyloxy groups, to a mixture heated to boiling of
vann, metanol, iseddik og jernpulver. Oksimet som derved danner seg intermediært, forsåpes straks til det tilsvarende keton, som ved -behandling med vandig ammoniak ved værelsetemperatur lar seg omdanne til det tilsvarende imin, som ikke isoleres, men umiddelbart kan reduseres til en eventuelt ennå med beskyttelsesgrupper beskyttet forbindelse med formel I, idet eventuelt ennå tilstedeværende aralkylgrupper kan avspaltes ved hydrogenolyse, tilstedeværende acylgrupper ved hydrolyse. water, methanol, glacial acetic acid and iron powder. The oxime that is thereby formed as an intermediate is immediately saponified into the corresponding ketone, which, by treatment with aqueous ammonia at room temperature, can be converted into the corresponding imine, which is not isolated, but can be immediately reduced to a compound of formula I, possibly still protected by protective groups , since any aralkyl groups still present can be split off by hydrogenolysis, acyl groups present by hydrolysis.
De som utgangssubstanser anvendte forbindelser med den generelle formel II, hvor X er en 2-hydroksyimino-2-alkyl-etyl-gruppe, kan fremstilles på i og for seg kjent måte, f.eks. ved at man opp-varmer til koking et tilsvarende ringsubstituert benzaldehyd, i hvilket frie hydroksygrupper er erstattet med acyloksy- eller aralkyloksy-grupper, hensiktsmessig i nærvær av et amin, som n-butylamin eller benzylamin eller et ammoniumsalt, som ammoniumacetat, med et alkylsubstituert nitrometan, avkjoler reaksjonsblandingen, ihnd.amper og. reduserer det tilbakeblivende ringsubstituerte f3-nitro-(3-aIkyl-styrol. ved hjelp av nasserende hydrogen [sink/saltsyre] eller ved hjelp av katalytisk aktivert hydrogen [palladiumkull] til det tilsvarende oksim med formel II, som deretter kan reduseres til en forbindelse med formel II, hvor X The compounds of the general formula II used as starting substances, where X is a 2-hydroxyimino-2-alkyl-ethyl group, can be prepared in a manner known per se, e.g. by heating to boiling a corresponding ring-substituted benzaldehyde, in which free hydroxy groups have been replaced by acyloxy or aralkyloxy groups, suitably in the presence of an amine, such as n-butylamine or benzylamine or an ammonium salt, such as ammonium acetate, with an alkyl-substituted nitromethane, cools the reaction mixture, ihnd.amper and. reduces the remaining ring-substituted 3-nitro-(3-alkyl-styrene) by means of nascent hydrogen [zinc/hydrochloric acid] or by means of catalytically activated hydrogen [palladium charcoal] to the corresponding oxime of formula II, which can then be reduced to a compound of formula II, where X
1<3>1<3>
er en -Cb^-CH-Nh^-griippe, idet eventuelt . ennå tilstedeværende aralkylgrupper kan avspaltes ved hydrogenolyse, tilstedeværende acylgrupper ved hydrolyse. is a -Cb^-CH-Nh^-griippe, as possibly . aralkyl groups still present can be split off by hydrogenolysis, acyl groups present by hydrolysis.
En tilstedeværende 2-imino- henh.. 2-hydroksyimino-2-alkyl-etyl-gruppe X kan fordelaktig på katalytisk måte .reduseres til onsket 2-amino-2-alkyl-etylgruppe X. Reduksjonen gjennomføres hensiktsmessig ved katalytisk aktivert hydrogen i et inert opplosningsmiddel, som f.eks. metanol i et mellom værelsetemperatur og kokepunktet for oppldsningsmidlet liggende temperaturområde ved normalt eller- dket trykk. Som katalysatorer er egnet f.eks. A present 2-imino-hen.. 2-hydroxyimino-2-alkyl-ethyl group X can advantageously be catalytically reduced to the desired 2-amino-2-alkyl-ethyl group X. The reduction is suitably carried out by catalytically activated hydrogen in a inert solvent, such as e.g. methanol in a temperature range between room temperature and the boiling point of the solvent at normal pressure. Suitable catalysts are e.g.
enten Raney-nikkel eller edelmetaller, som platina eller palladium eller''Raney-kobolt. either Raney nickel or precious metals, such as platinum or palladium or ''Raney cobalt.
Reduksjonen kan videre også gjennomfdres ved hjelp av komplekse metallhydrider, som natrium- eller litiumborhydrid., Anvender The reduction can also be carried out using complex metal hydrides, such as sodium or lithium borohydride., Uses
man f.eks. Raney-nikkel, platina eller palladium som katalysatorer så fjernes samtidig tilstedeværende aralkylgrupper, f.eks. benzylgrupper. Gjennomfører man derimot reduksjonen ved hjelp av Raney-kobolt eller natrium- henh. litiumborhydrid, så behol-des tilstedeværende aralkylgrupper. De kan ved hydrogenolyse f.eks. avspaltes ved hjelp av Raney-nikkel, platina eller palladium. one e.g. Raney-nickel, platinum or palladium as catalysts then simultaneously present aralkyl groups are removed, e.g. benzyl groups. On the other hand, the reduction is carried out using Raney cobalt or sodium respectively. lithium borohydride, then the aralkyl groups present are retained. They can by hydrogenolysis e.g. is cleaved using Raney nickel, platinum or palladium.
Tilstedeværende acylgrupper, f.eks. acetylgrupper kan avspaltes ved sur eller alkalisk hydrolyse, fortrinnsvis ved innvirkning av mineralsyrer, f.eks. med fortynnet saltsyre i en alkanol, Acyl groups present, e.g. acetyl groups can be split off by acid or alkaline hydrolysis, preferably by the action of mineral acids, e.g. with dilute hydrochloric acid in an alkanol,
som metanol eller ved behandling med alkali, f.eks. med natrium-hydroksyd i en vandig alkanol, som metanol, i et mellom 20 og 100°C liggende temperaturområde. as methanol or by treatment with alkali, e.g. with sodium hydroxide in an aqueous alkanol, such as methanol, in a temperature range between 20 and 100°C.
Aminene med formel I faller ut som racemater. Disse kan skilles etter kjente metoder, f.eks. ved hjelp, av optisk aktive syrer The amines of formula I precipitate as racemates. These can be separated according to known methods, e.g. by means of optically active acids
• som vinsyre. • as tartaric acid.
Aminene med formel I danner med uorganiske eller organiske syrer addisjonssalter. Som eksempler kan nevnes: salter med halogen-hydrogensyrer, spesielt med klor- eller brom-hydrogensyre, eller salter med svovelsyre eller også med organiske syrer, f.eks. med benzosyre, eddiksyre, vinsyre, sitronsyre eller melkesyre. The amines of formula I form addition salts with inorganic or organic acids. As examples can be mentioned: salts with halogen-hydrogen acids, especially with chloro- or bromo-hydrogen acid, or salts with sulfuric acid or also with organic acids, e.g. with benzoic acid, acetic acid, tartaric acid, citric acid or lactic acid.
De ifolge oppfinnelsen fremstillbare fenetylaminer er hypotensivt virksomme. Forbindelser med formel I, hvor R^ og R2 betyr en alkoksygruppe eller en hydroksygruppe og R^ en alkylgruppe, inntar en f ortrinnsstilling, er foretrukket. Som hypotensivt særlig godt vi-rksomt har 3, 5-dihydroksy- 4-metoksy-a-metyl-f enetylamin vist seg. Toksisiteten av denne forbindelse er meget lav. Hos mus ligger den letale dose [lD^0J ved oral administrasjon på mer enn 5000 mg/kg. Den blodtrykkssenkende virkning opptrer hos mus allerede ved en dose på 3 mg p.o./kg. Enkeltdosen kan okes inntil 200 mg/kg. 3,4-dihydroksy-5-metoksy-a-metyl-fenetylamin har lignende egenskaper. The phenethylamines that can be prepared according to the invention are hypotensive active. Compounds of formula I, where R 1 and R 2 mean an alkoxy group or a hydroxy group and R 1 an alkyl group, occupying a fourth position, are preferred. 3,5-dihydroxy-4-methoxy-α-methyl-phenethylamine has been shown to be particularly effective as a hypotensive agent. The toxicity of this compound is very low. In mice, the lethal dose [lD^0J by oral administration is more than 5000 mg/kg. The blood pressure-lowering effect occurs in mice already at a dose of 3 mg p.o./kg. The single dose can be increased up to 200 mg/kg. 3,4-dihydroxy-5-methoxy-α-methyl-phenethylamine has similar properties.
De nye hypotensivt virksomme fenetylaminderivater står de i det franske patent nr. 2644 M beskrevne forbindelser som har prak-tisk talt like sterke blodtrykkssenkende egenskaper. Sistnevnte forbindelser har dog, slik som det kunne påvises ved 2,4,5-trihydroksy-a-metyl-fenetylamin, bivirkninger som har en irrever-sibel beskadigelse av sympatiske nerveender til folge. Frem-gangsmåt eproduktene , f.eks. 3,4,5-trihydroksy-a-metyl-fenetylamin, forårsaker derimot ingen morfologiske forandringer i nerveendene og kan derfor uten betenkning anvendes for behandling av hypertoni. The new hypotensively active phenethylamine derivatives are the compounds described in French patent no. 2644 M, which have practically equally strong blood pressure-lowering properties. The latter compounds, however, as could be demonstrated with 2,4,5-trihydroxy-α-methyl-phenethylamine, have side effects that result in irreversible damage to sympathetic nerve endings. Procedure the e-products, e.g. 3,4,5-trihydroxy-α-methyl-phenethylamine, on the other hand, causes no morphological changes in the nerve endings and can therefore be used without hesitation for the treatment of hypertension.
Den blodtrykkssenkende effekt av fremgangsmåteproduktene er sam-menlignbare med virkningen av a-metyldopa. De ifolge oppfinnelsen fremstillbare fenetylaminer kan derfor anvendes som hypotensivt virksomt middel til bekjempelse av sykelige hoye blod-trykk, spesielt som middel mot den essensielle hypertoni. The blood pressure-lowering effect of the process products is comparable to the effect of α-methyldopa. The phenethylamines that can be prepared according to the invention can therefore be used as hypotensive agents for combating morbidly high blood pressure, especially as a remedy for essential hypertension.
Fremgangsmåteproduktene er hvite, krystalline forbindelser. De har basiske og sure egenskaper og kan anvendes som base og i form av deres syreaddisjonssalter. Saltene er karakteristiske, krystalline forbindelser, som er lett opploselige i vann. I polare opplosningsmidler, f.eks. i metanol, etanol og lignende andre alkanoler opploser de seg mindre godt. I upolare opplosningsmidler, f.eks. i benzen, eter, petroleter er saltene prak-tisk talt uoppløselige. For de fire aminer er metanol et godt opplosningsmiddel. The process products are white, crystalline compounds. They have basic and acidic properties and can be used as a base and in the form of their acid addition salts. The salts are characteristic, crystalline compounds, which are easily soluble in water. In polar solvents, e.g. in methanol, ethanol and similar other alkanols they dissolve less well. In non-polar solvents, e.g. in benzene, ether, petroleum ether the salts are practically insoluble. For the four amines, methanol is a good solvent.
Forbindelsene med formel I kan derfor finne anvendelse som legemiddel, f.eks. i form av farmasbytiske preparater, som inneholder disse forbindelser eller deres salter i blanding med en for den enterale eller parenterale administrasjon egnet farma-søytisk, organisk eller uorganisk inert bærer. The compounds of formula I can therefore find use as medicine, e.g. in the form of pharmaceutical preparations, which contain these compounds or their salts in admixture with a pharmaceutical, organic or inorganic inert carrier suitable for enteral or parenteral administration.
EKSEMPEL 1 EXAMPLE 1
13,5 g 3',5'-dibenzyloksy-4'-metoksy-2-imino-propyl-benzen - fremstilt fra 13,9 g (3,5-dibenzyloksy-4-metoksy-fenyl)-aceton og 81 ml 25 %' ig vandig ammoniakki 250 ml absolutt metanol - hydreres ved hjelp av 3 g Raney-nikkel under normalbetinqelser. Hydreringsprosessen avbrytes etter opptagelse av 1100 ml hydrogen. Katalysatoren filtreres fra og vaskes med 50 ml metanol. Det med vaskemetanolen forente filtrat inndampes under forminsket trykk. Den mdrkebruntfargede rest opptas i 200 ml eter, vaskes to ganger hver gang med 50 ml 2-n saltsyre og en gang med 150 ml vann. Den vandige faseskilles fra, ekstraheres med 200 ml eter. Ekstraktet konsentreres under forminsket trykk til 100 ml og fordeles deretter mellom 100 ml av en mettet, vandig kaliumkarbonat-oppldsning og 200 ml eter. Den vandige fase ekstraheres ennå en gang med 200 ml eter. Ekstraktene forenes, tdrkes over natriumsulfat og inndampes under forminsket trykk. Det tilbakeblivende 3,5-dibenzyloksy-4-metoksy-oc-metyl-f enetylamin opploses i 130 ml absolutt metanol og 26 ml 2-n vandig saltsyre og hydreres etter tilsetning av 1,3 g 5 %'ig palladiumkull under normalbetingelser. Hydreringen kommer til stillstand etter opptagelse av 570 ml hydrogen. Katalysatoren filtreres fra. og vaskes med 50 ml metanol. Det med vaskemetanolen forente filtrat inndampes under forminsket trykk. Det tilbakeblivende 3,5-dihydroksy-4-metoksy-a-metyl-fenetylamin-hydroklorid smelter etter to gangers omkrystallisasjon fra acetonitril/metanol ved 222 - 224°C. 13.5 g of 3',5'-dibenzyloxy-4'-methoxy-2-imino-propyl-benzene - prepared from 13.9 g of (3,5-dibenzyloxy-4-methoxy-phenyl)-acetone and 81 ml 25 % aqueous ammonia 250 ml absolute methanol - is hydrated with the aid of 3 g Raney nickel under normal conditions. The hydration process is interrupted after absorption of 1100 ml of hydrogen. The catalyst is filtered off and washed with 50 ml of methanol. The filtrate combined with the washing methanol is evaporated under reduced pressure. The dark brown residue is taken up in 200 ml of ether, washed twice each time with 50 ml of 2-N hydrochloric acid and once with 150 ml of water. The aqueous phase is separated from, extracted with 200 ml of ether. The extract is concentrated under reduced pressure to 100 ml and then distributed between 100 ml of a saturated aqueous potassium carbonate solution and 200 ml of ether. The aqueous phase is extracted once more with 200 ml of ether. The extracts are combined, dried over sodium sulphate and evaporated under reduced pressure. The remaining 3,5-dibenzyloxy-4-methoxy-oc-methyl-phenethylamine is dissolved in 130 ml of absolute methanol and 26 ml of 2-N aqueous hydrochloric acid and hydrated after adding 1.3 g of 5% palladium charcoal under normal conditions. The hydrogenation stops after absorption of 570 ml of hydrogen. The catalyst is filtered off. and washed with 50 ml of methanol. The filtrate combined with the washing methanol is evaporated under reduced pressure. The remaining 3,5-dihydroxy-4-methoxy-α-methyl-phenethylamine hydrochloride melts after two recrystallizations from acetonitrile/methanol at 222 - 224°C.
Det for fremstillingen av utgangsforbindelsen nddvendige (3,5-dibenzyloksy-4-metoksy-fenyl)-aceton kan fremstilles som folger: 30 g 3,5-dibenzyloksy-4-metoksy-benzaldehyd oppvarmes sammen med 150 ml nitroetan og 5,06 g •ammoniumacetat i en argonatmosfære i 20 timer til koking. Etter avkjdling inndampes reaksjonsblandingen under forminsket trykk. Resten opptas i 500 ml metylenklorid.. Oppløsningen vaskes i rekkefolge med hver 200 ml vann, 200 ml "2-n vandig svovelsyre, 200 ml vann, 200 ml av . en mettet, vandig natriumbikarbonatoppldsning og tilslutt med 200 ml vann, tdrkes over natriumsulfat og inndampes under forminsket trykk. Det til-bak ebli.vendé 3 '■ ,51 -dibenzyloksy-4 ' -metoksy-2-nitro-prope-nyl-benzen smelter ved 100 - 103°C. The (3,5-dibenzyloxy-4-methoxy-phenyl)-acetone required for the preparation of the starting compound can be prepared as follows: 30 g of 3,5-dibenzyloxy-4-methoxy-benzaldehyde are heated together with 150 ml of nitroethane and 5.06 g •ammonium acetate in an argon atmosphere for 20 hours until boiling. After cooling, the reaction mixture is evaporated under reduced pressure. The residue is taken up in 500 ml of methylene chloride. The solution is washed successively with each 200 ml of water, 200 ml of 2-n aqueous sulfuric acid, 200 ml of water, 200 ml of a saturated, aqueous sodium bicarbonate solution and finally with 200 ml of water, dried over sodium sulphate and evaporated under reduced pressure. The resulting 3'■,51-dibenzyloxy-4'-methoxy-2-nitro-propenyl-benzene melts at 100 - 103°C.
39.8 g av denne forbindelse innfores i ldpet av 8 timer i en kokende blanding av 140 ml vann, 190 ml etanol, 9,1 ml iseddik og 33,6 g jernpulver. Reaksjonsblandingen vidererdres deretter ytterligere i 8 timer under tilbakeldpsbetingelser, avkjdles deretter og ved en temperatur mellom 10 og 20°C tilsettes dråpevis 72 ml 3-n vandig saltsyre og 23 ml konsentrert saltsyre (37 %). Blandingen ekstraheres med 500 ml benzen/eddiksyreetylester (1:1). Ekstraktet vaskes to ganger hver gang med 200 ml 2-n vandig saltsyre, to ganger hver gang med 200 ml vann og en gang med 200 ml av en mettet, vandig natriumbikarbonatopp-losning, tdrkes over natriumsulfat, renses ved rystning med aktivkull, filtreres og inndampes under forminsket trykk. Det tilbakeblivende (3,5-dibenzyloksy-4-metoksy-fenyl)-aceton smelter etter tre gangers omkrystallisasjon fra metanol ved 67 - 69°C. 39.8 g of this compound are introduced over a period of 8 hours into a boiling mixture of 140 ml of water, 190 ml of ethanol, 9.1 ml of glacial acetic acid and 33.6 g of iron powder. The reaction mixture is then further stirred for 8 hours under reflux conditions, then cooled and at a temperature between 10 and 20°C, 72 ml of 3-n aqueous hydrochloric acid and 23 ml of concentrated hydrochloric acid (37%) are added dropwise. The mixture is extracted with 500 ml of benzene/ethyl acetate (1:1). The extract is washed twice each time with 200 ml of 2-N aqueous hydrochloric acid, twice each time with 200 ml of water and once with 200 ml of a saturated, aqueous sodium bicarbonate solution, dried over sodium sulfate, purified by shaking with activated carbon, filtered and evaporated under reduced pressure. The remaining (3,5-dibenzyloxy-4-methoxy-phenyl)-acetone melts after three recrystallizations from methanol at 67 - 69°C.
EKSEMPEL 2 EXAMPLE 2
7,8 g 3 ,5-dibenzyloksy-4-metoksy-cc-metyl-f enetylamin-hydroklorid opploses i 400 ml absolutt metanol og hydreres ved hjelp av 1,5 g 5 %' ig palladiumkull under normalbetingelser. Hydreringen kommer til stillstand etter opptagelse av ca. 860 ml hydrogen. Katalysatoren filtreres fra. Filtratet inndampes under forminsket trykk. Det tilbakeblivende 3,5-dihydroksy-4-metoksy-a-metyl-fenetylamin-hydroklorid smelter etter to gangers omkrystallisasjon fra acetonitril/metanol ved 223 - 224°C. 7.8 g of 3,5-dibenzyloxy-4-methoxy-cc-methyl-phenethylamine hydrochloride is dissolved in 400 ml of absolute methanol and hydrated with the aid of 1.5 g of 5% palladium charcoal under normal conditions. The hydration comes to a standstill after absorption of approx. 860 ml of hydrogen. The catalyst is filtered off. The filtrate is evaporated under reduced pressure. The remaining 3,5-dihydroxy-4-methoxy-α-methyl-phenethylamine hydrochloride melts after two recrystallizations from acetonitrile/methanol at 223 - 224°C.
Det som utgangsforbindelse anvendte 3,5-dibenzyloksy-4-metoksy-a-metyl-fenetylamin-hydroklorid kan f.eks. fremstilles på fol-gende måte: 20.9 g litiumaluminiumhydrid suspenderes i 400 ml absolutt eter og tilsettes 200 ml tetrahydrofuran. Til denne blanding innfores dråpevis under roring og gassing med argon 27 g 3',5'-dibenzyloksy-4 1-meto.ksy-2-nitropropenyl-benzen i 400 ml tetrahydrofuran på den- måte at temperaturen for reaksjonsblandingen holdes mellom 35 pg 40°C. Blandingen rdres etter avsluttet inn-føring i ytterligere 4 timer under tilbakeldpsbetingelser, spaltes under avkjoling med is/metanol ved forsiktig tilsetning av 82 ml vann og oppvarmes kort til koking. Aluminiumoksydet, som faller ut som flak, filtreres fra og kokes ut to ganger hver gang med 200 ml tetrahydrofuran. Tetrahydrofuranfiltratene forenes med hovedfiltratet og inndampes under forminsket trykk. Resten opptas i 500 ml benzen, vaskes med 100 ml av en mettet, vandig natriumkarbonatoppldsning, tdrkes over kaliumkarbonat, filtreres og inndampes under forminsket 'trykk. Det tilbakeblivende olje-■aktige 3,5-dibenzyloksy-4-metoksy-a-metyl-fenetylamin oppldses i 150 ml l-n etanolisk saltsyre. Oppldsningen inndampes under forminsket trykk. Det tilbakeblivende 3,5-dibenzyloksy-4-metol<-sy-a-metyl-fenetylamin-hydroklorid smelter etter to gangers omkrystallisas jon fra eddiksyreetylester og metanol ved 135 - The 3,5-dibenzyloxy-4-methoxy-α-methyl-phenethylamine hydrochloride used as starting compound can e.g. is prepared in the following way: 20.9 g of lithium aluminum hydride is suspended in 400 ml of absolute ether and 200 ml of tetrahydrofuran is added. To this mixture, 27 g of 3',5'-dibenzyloxy-4-1-methoxy-2-nitropropenyl-benzene in 400 ml of tetrahydrofuran are added dropwise while stirring and gassing with argon in such a way that the temperature of the reaction mixture is kept between 35 and 40 °C. After completion of the introduction, the mixture is stirred for a further 4 hours under reflux conditions, split while cooling with ice/methanol by the careful addition of 82 ml of water and briefly heated to boiling. The aluminum oxide, which falls out as flakes, is filtered off and boiled out twice each time with 200 ml of tetrahydrofuran. The tetrahydrofuran filtrates are combined with the main filtrate and evaporated under reduced pressure. The residue is taken up in 500 ml of benzene, washed with 100 ml of a saturated, aqueous sodium carbonate solution, dried over potassium carbonate, filtered and evaporated under reduced pressure. The remaining oily 3,5-dibenzyloxy-4-methoxy-α-methyl-phenethylamine is dissolved in 150 ml of 1-1 ethanolic hydrochloric acid. The solution is evaporated under reduced pressure. The remaining 3,5-dibenzyloxy-4-methol<-sy-a-methyl-phenethylamine hydrochloride melts after two recrystallizations from acetic acid ethyl ester and methanol at 135 -
EKSEMPEL 3 EXAMPLE 3
16 g 3,5-dibenzyloksy-4-metoksy-a-etyl-fenetylamin-hydroklorid 16 g 3,5-dibenzyloxy-4-methoxy-α-ethyl-phenethylamine hydrochloride
innfores i 200 ml absolutt metanol og hydreres ved hjelp av 3 g introduced into 200 ml of absolute methanol and hydrated with the help of 3 g
5 %' ig palladiurnkull under normalbetingelser. Hydreringen kommer 5% palladium coal under normal conditions. The hydration is coming
til stillstand etter ca. 1 time. Katalysatoren filtreres fra. Filtratet inndampes under forminsket trykk. Det tilbakeblivende 3,5-dihydroksy-4-metoksy-a-etyl-fenetylamin krystalliserer etter digerering med acetonitril. Den sterkt hygroskopiske forbindelse smelter etter to gangers omkrystallisasjon fra acetonitril/metanol ved 160 - 163°C. to a standstill after approx. 1 hour. The catalyst is filtered off. The filtrate is evaporated under reduced pressure. The remaining 3,5-dihydroxy-4-methoxy-α-ethyl-phenethylamine crystallizes after digestion with acetonitrile. The highly hygroscopic compound melts after two recrystallizations from acetonitrile/methanol at 160 - 163°C.
Det som utgangsforbindelse anvendte 3,5-dibenzyloksy-4-metoksy-a-etyl-fenetylamin-hydroklorid kan fremstilles på fdlgende måte: 50 g 3,5-dibenzyloksy-4-metoksy-benzaldehyd oppvarmes sammen med 8,3 g ammonijacetat og 287 ml 1-nitropropan i 20 timer i en inert gassatmosfære under tilbakeldpsbetingelser. Reaksjonsblandingen avkjdles så og inndampes under forminsket trykk. Resten opptas i 600 benzen. Oppldsningen vaskes i rekkefolge med hver 200 ml vann, 200 ml vandig 2-n svovelsyre, 200 ml vann, 200 ml av en mettet, vandig natfiumbikarbonatoppldsning og 200 ml vann, torkes over natriumsulfat under tilsetning av aktivkull, filtreres og inndampes under forminsket trykk. Det tilbakeblivende 3',5'-dibenzyloksy-4'-metoksy-(2-nitro-1-butenyl)-benzen omkrystalli-seres fra metanol og deretter fra eter. -Forbindelsen smelter ved 68 - 69°C. 22 g litiumalurniniumhydrid suspenderes i 400 ml absolutt eter og tilsettes 200 ml absolutt tetrahydrofuran. Til denne blanding innfores dråpevis under rdring og gassing med argon 29 g 3',5'-dibenzyloksy-4'-metoksy-(2-nitro-l-butenyl)-benzen i 400 ml absolutt tetrahydrofuran på den måte at temperaturen for reaksjonsblandingen holdes mellom 3b og 40°C. Blandingen rdres etter avsluttet innfdring ytterligere i 4 timer under tilbakeldpsbetingelser, spaltes så under avkjdling med is/metanol ved forsiktig tilsetning av 88 ml vann og oppvarmes kort til koking. Aluminiumoksydet, som faller ut som flak, filtreres fra og kokes ut to ganger hver gang med 1000 ml tetrahydrofuran. Tetrahydrofuranfiltratene forenes med hovedfiltratet og inndampes under forminsket trykk. Resten opptas i 500 ml benzen. Oppldsningen rystes med 200 ml av en mettet, vandig natriumkarbonatoppldsning, tdrkes over kaliumkarbonat, filtreres og inndampes under forminsket trykk. Det. tilbakeblivende 3 ,5-dibenzyloks y-4 - metoksy-a-etyl-fenetylamin oppldses i 100 ml l-n etanolisk saltsyre. Oppldsningen inndampes under forminsket trykk. Det tilbakeblivende 3,5-dibenzyloksy-4-metoks y-a-etyl-fenetylamin-hydroklorid smelter etter to gangers omkrystallisas jon fra tneta-noi/eter ved 148 - 150°C. The 3,5-dibenzyloxy-4-methoxy-α-ethyl-phenethylamine hydrochloride used as starting compound can be prepared in the following way: 50 g of 3,5-dibenzyloxy-4-methoxy-benzaldehyde is heated together with 8.3 g of ammonium acetate and 287 ml of 1-nitropropane for 20 hours in an inert gas atmosphere under reflux conditions. The reaction mixture is then cooled and evaporated under reduced pressure. The rest is taken up in 600 benzene. The solution is washed successively with 200 ml of water, 200 ml of aqueous 2-n sulfuric acid, 200 ml of water, 200 ml of a saturated, aqueous sodium bicarbonate solution and 200 ml of water, dried over sodium sulphate while adding activated carbon, filtered and evaporated under reduced pressure. The remaining 3',5'-dibenzyloxy-4'-methoxy-(2-nitro-1-butenyl)-benzene is recrystallized from methanol and then from ether. -The compound melts at 68 - 69°C. 22 g of lithium alurninium hydride are suspended in 400 ml of absolute ether and 200 ml of absolute tetrahydrofuran are added. To this mixture, 29 g of 3',5'-dibenzyloxy-4'-methoxy-(2-nitro-1-butenyl)-benzene in 400 ml of absolute tetrahydrofuran are introduced dropwise under stirring and gassing with argon in such a way that the temperature of the reaction mixture is maintained between 3b and 40°C. After completion of the introduction, the mixture is stirred for a further 4 hours under reflux conditions, then split while cooling with ice/methanol by the careful addition of 88 ml of water and heated briefly to boiling. The aluminum oxide, which falls out as flakes, is filtered off and boiled twice each time with 1000 ml of tetrahydrofuran. The tetrahydrofuran filtrates are combined with the main filtrate and evaporated under reduced pressure. The residue is taken up in 500 ml of benzene. The solution is shaken with 200 ml of a saturated, aqueous sodium carbonate solution, dried over potassium carbonate, filtered and evaporated under reduced pressure. The. residual 3,5-dibenzyloxy y-4-methoxy-α-ethyl-phenethylamine is dissolved in 100 ml 1-1 ethanolic hydrochloric acid. The solution is evaporated under reduced pressure. The remaining 3,5-dibenzyloxy-4-methoxy γ-α-ethyl-phenethylamine hydrochloride melts after two recrystallizations from ether at 148-150°C.
EKSEMPEL 4 EXAMPLE 4
3,9 g 3',5<1->dibenzyloksy-4'-metoksy-2-hydroksyiminopropylbenzen innfores i 80 ml absolutt metanol og hydreres etter tilsetning av 2 ml konsentrert vandig saltsyre ved hjelp av 0,5 g platinaoksyd under normalbetingelser. Etter opptagelse av 1785 ml hydrogen filtreres katalysatoren fra og vaskes med 20 ml metanol. Filtratet inndampes under forminsket trykk. Det tilbakeblivende 3,5-dihydroksy-4-metoksy-a-metyl-f enetylamin-hydroklorid smelter etter to gangers omkrystallisasjon fra metanol ved 222 - 224°C. 3.9 g of 3',5<1->dibenzyloxy-4'-methoxy-2-hydroxyiminopropylbenzene are introduced into 80 ml of absolute methanol and hydrated after the addition of 2 ml of concentrated aqueous hydrochloric acid using 0.5 g of platinum oxide under normal conditions. After absorption of 1785 ml of hydrogen, the catalyst is filtered off and washed with 20 ml of methanol. The filtrate is evaporated under reduced pressure. The remaining 3,5-dihydroxy-4-methoxy-α-methyl-phenethylamine hydrochloride melts after two recrystallizations from methanol at 222 - 224°C.
Det som utgangsforbindelse anvendte 3',5'-bis-benzyloksy-4'-metoksy-2-hydroksyiminopropyl-benzen kan f.eks. fremstilles som folger: 7,52 g [ 3,5-dibenzyloksy-4-metoksy-fenyl]-aceton, 1,34 g hydrok-sylaminhydroklorid, 1,4 ml absolutt pyridin og 20 ml absolutt etanol oppvarmes sammen i 2 timer under tilbakeldpsbetingelser. Reaksjonsblandingen inndampes deretter under forminsket trykk. Resten deles mellom 100 ml iddiksyreetylester og 50 ml vann. The 3',5'-bis-benzyloxy-4'-methoxy-2-hydroxyiminopropyl benzene used as starting compound can e.g. is prepared as follows: 7.52 g [3,5-dibenzyloxy-4-methoxy-phenyl]-acetone, 1.34 g hydroxylamine hydrochloride, 1.4 ml absolute pyridine and 20 ml absolute ethanol is heated together for 2 hours under reflux conditions. The reaction mixture is then evaporated under reduced pressure. The residue is divided between 100 ml of acetic acid ethyl ester and 50 ml of water.
Den organiske fase vaskes i rekkefolge med to ganger hver gang 50 ml 2-n vandig svovelsyre, to ganger hver gang med 50 ml vann, The organic phase is washed in sequence with twice each time 50 ml of 2-n aqueous sulfuric acid, twice each time with 50 ml of water,
en gang med 100 ml av en mettet, vandig natriumbikarbonatoppldsning, tdrkes over natriumsulfat og inndampes under forminsket trykk. Det tilbakeblivende 3', 51-dibenzyloksy-41-metoksy-2-hydroksyiminopropyl-benzen smelter etter omkrystallisasjon fra toluen/petroleter ved 105 - 113°C. once with 100 ml of a saturated, aqueous sodium bicarbonate solution, dried over sodium sulfate and evaporated under reduced pressure. The remaining 3', 51-dibenzyloxy-41-methoxy-2-hydroxyiminopropylbenzene melts after recrystallization from toluene/petroleum ether at 105-113°C.
EKSEMPEL 5 EXAMPLE 5
3,9 g 3' ,5'-dibenzyloksy-4'-metoksy-2-hydroksyiminopropyl-benzen innfores i 100 ml absolutt metanol og hydreres ved hjelp av 1 g 5 %'ig palladiumkull under normalbetingelser. Hydreringen kommer til stillstand etter opptagelse av 500 ml hydrogen. Katalysatoren filtreres fra. Filtratet inndampes under forminsket trykk. Det tilbakeblivende 3',5<1->dihydroksy-4'-metoksy-2-hydrok-syiminopropyl-benzen smelter etter to gangers omkrystallisasjon fra vann ved 137°C. 3.9 g of 3',5'-dibenzyloxy-4'-methoxy-2-hydroxyiminopropylbenzene are introduced into 100 ml of absolute methanol and hydrated with the aid of 1 g of 5% palladium charcoal under normal conditions. The hydrogenation comes to a standstill after 500 ml of hydrogen has been absorbed. The catalyst is filtered off. The filtrate is evaporated under reduced pressure. The remaining 3',5<1->dihydroxy-4'-methoxy-2-hydroxy-cyiminopropyl-benzene melts after two recrystallizations from water at 137°C.
2 g 3',5'-dihydroksy-4'-metoksy-2-hydroksyiminopropyl-benzen 2 g 3',5'-dihydroxy-4'-methoxy-2-hydroxyiminopropyl-benzene
innfores i 50 ml metanol og hydreres etter tilsetning av 10 ml vandig konsentrert saltsyre over 0,2 g platinaoksyd under normalbetingelser. Etter opptagelse av den beregnede mengde hydrogen filtreres katalysatoren fra. Filtratet inndampes under forminsket trykk. Det tilbakeblivende 3 ,5-dihydroksy-4-metoksy-oc-metyl-fenetylamin-hydroklorid smelter etter to gangers omkrystallisasjon fra metanol/acetonitril ved 222 - 224°C. introduced into 50 ml of methanol and hydrated after adding 10 ml of aqueous concentrated hydrochloric acid over 0.2 g of platinum oxide under normal conditions. After absorption of the calculated amount of hydrogen, the catalyst is filtered off. The filtrate is evaporated under reduced pressure. The remaining 3,5-dihydroxy-4-methoxy-oc-methyl-phenethylamine hydrochloride melts after two recrystallizations from methanol/acetonitrile at 222 - 224°C.
EKSEMPEL 6 EXAMPLE 6
12 g 3,5-dibenzoyloksy-4-metoksy-a-metyl-fenetylamin-hydroklorid oppvarmes med 120 ml vandig 4-n saltsyre i en inert gassatmosfære i 14 timer til. koking. Reaksjonsblandingen avkjdles så til 0°. Den utfelte benzosyre filtreres fra og vaskes med 50 ml vann. Det med vaskevannet forente filtrat inndampes under forminsket trykk. Det tilbakeblivende 3,5-dihydroksy-4-metoksy-a-metyl-fenetylamin-hydroklorid smelter etter to gangers omkrystallisasjon fra metanol ved 221 - 224°C. 12 g of 3,5-dibenzoyloxy-4-methoxy-α-methyl-phenethylamine hydrochloride are heated with 120 ml of aqueous 4-n hydrochloric acid in an inert gas atmosphere for a further 14 hours. cooking. The reaction mixture is then cooled to 0°. The precipitated benzoic acid is filtered off and washed with 50 ml of water. The filtrate combined with the washing water is evaporated under reduced pressure. The remaining 3,5-dihydroxy-4-methoxy-α-methyl-phenethylamine hydrochloride melts after two recrystallizations from methanol at 221 - 224°C.
Det som utgangsforbindelse anvendte 3,5-dibenzoyloksy-4-metoksy-oc-metyl-f enetylamin-hydrok lorid kan f.eks. fremstilles som folger: 19,6 g 3,5-dibenzoyloksy-p-anissyre, 20 ml friskt destillert tionylklorid og 50 ml absolutt kloroform oppvarmes i en inert. gassatmosfære i 1 time under tilbakeldpsbetingelser. Reaksjonsblandingen konsentreres så. Konsentratet opptas i 100 ml absolutt benzen og filtreres over aluminiumoksyd. Det etter inndampning av eluatet tilbakeblivende gule, halvfaste 3,5-dibenzoyloksy-p-anissyreklorid kan umiddelbart anvendes videre som folger. The 3,5-dibenzoyloxy-4-methoxy-oc-methyl-phenethylamine hydrochloride used as starting compound can e.g. is prepared as follows: 19.6 g of 3,5-dibenzoyloxy-p-anisic acid, 20 ml of freshly distilled thionyl chloride and 50 ml of absolute chloroform are heated in an inert. gas atmosphere for 1 hour under reflux conditions. The reaction mixture is then concentrated. The concentrate is taken up in 100 ml of absolute benzene and filtered over aluminum oxide. The yellow, semi-solid 3,5-dibenzoyloxy-p-anisic acid chloride remaining after evaporation of the eluate can be immediately used further as a follow-on.
40 g 3,5-dibenzoyloksy-p-anissyreklorid hydreres i nærvær av 40 g of 3,5-dibenzoyloxy-p-anisic acid chloride are hydrated in the presence of
11 g av en partiell med kinolin desaktivert. palladium/barium-sulfat-katalysator i 250 ml kokende absolutt xylen. Reaksjons-oppldsningen filtreres varm etter avslutning av saltsyregassut-viklingen [ca. etter 2,5 timer]. Filtratet konsentreres under forminsket trykk. Det tilbakeblivende oljelignende 3,5-dibenzoyloksy-p-anisaldehyd bringes til krystallisasjon etter tilsetning av petroleter. Aldehydet smelter etter omkrystallisasjon fra eter/petroleter ved 101 - 102°C. 12 g 3,5-dib_enzoyloksy-p-anissyrealdehyd og 4 g nitroetan oppvarmes sammen med 0,6 g eddiksyre og 0,23 g n-butylamin i 20 ml absolutt toluen i 15 timer under tilbakeldpsbetingelser. Det frittblivende vann oppfanges på en vannavskiller. Reaksjonsblandingen inndampes deretter under forminsket trykk. Det tilbakeblivende oljeaktige 3-' ,5 '-dibenzoyloksy-4 ' -metoksy-2-nitroprope-nyl-benzen krystalliserer fra isopropanol/diisopropyleter og smelter ved 102°C. 11 g of a partial with quinoline deactivated. palladium/barium sulfate catalyst in 250 ml of boiling absolute xylene. The reaction solution is filtered hot after completion of the evolution of hydrochloric acid gas [approx. after 2.5 hours]. The filtrate is concentrated under reduced pressure. The remaining oil-like 3,5-dibenzoyloxy-p-anisaldehyde is crystallized after the addition of petroleum ether. The aldehyde melts after recrystallization from ether/petroleum ether at 101 - 102°C. 12 g of 3,5-dibenzoyloxy-p-anisic acid aldehyde and 4 g of nitroethane are heated together with 0.6 g of acetic acid and 0.23 g of n-butylamine in 20 ml of absolute toluene for 15 hours under reflux conditions. The free water is collected on a water separator. The reaction mixture is then evaporated under reduced pressure. The residual oily 3-',5'-dibenzoyloxy-4'-methoxy-2-nitropropenyl-benzene crystallizes from isopropanol/diisopropyl ether and melts at 102°C.
I en til koketemperatur oppvarmet blanding av 25 g jernpulver, 105 ml vann, 140 ml metanol og 6,9 ml iseddik innfores under roring-i ldpet av 10 timer 29 g 31 ,5.'-diberizoyloksy-4 '-metoksy-2-nitropropenyl-benzen. Reaksjonsblandingen rdres deretter i ytterligere 14 timer under tilbakeldpsbetingelser, deretter tilsettes under isavkjdling 71 ml vandig 3-n saltsyre og 23 ml konsentrert vandig saltsyre og ekstraheres to ganger hver gang med 500 ml eddiksyreetylester. Eddik esteruttrekkene vaskes i rekkefolge to ganger med 200 ml 2-n saltsyre, to ganger med 200 nil vann og to ganger med 200 ml av en mettet, vandig natriumbikarbonatoppldsning, forenes så, tdrkes over natrium-sulf.at og inndampes under forminsket trykk. Det tilbakeblivende [3,5-dibenzoyloksy-4-metoksy-fenyl]-aceton smelter etter to gangers omkrystallisasjon fra eter ved 88 - 89°C. 10 g L3,5-dibenzoyloksy-4-metoksy-fenylj-aceton oppldses i 100 ml dioksan og hydreres etter tilsetning av 20 ml av en mettet, vandig ammoniakoppldsning ved hjelp av Raney-nikkel under normalbetingelser. Katalysatoren filtreres fra etter avsluttet hydrogen-opptagelse. Filtratet konsentreres ved 30°C under forminsket trykk til ca. 50 ml, fortynnes med 50 ml vann og ekstraheres deretter to ganger hver gang med 100 ml eddiksyreetylester. Eddikesteruttrekkene vaskes med 100 ml vann, forenes,'tdrkes over natriumsulfat og inndampes under forminsket trykk. Resten opptas i 10 ml vann. De uoppløselige deler filtreres fra. Filtratet tilsettes 50 ml eterisk saltsyre. Det utfelte oljelignende 3,5-dibenzoyloksy-4-metoks<y>-oc-metyl-fenetylamin-hydroklorid krystalliserer etter digerering med acetonitril og smelter etter og gangers omkrystallisasjon fra aceton/eter ved 127 - 128°C. Into a mixture heated to boiling temperature of 25 g of iron powder, 105 ml of water, 140 ml of methanol and 6.9 ml of glacial acetic acid, 29 g of 31,5.'-diberizoyloxy-4'-methoxy-2- nitropropenyl-benzene. The reaction mixture is then stirred for a further 14 hours under reflux conditions, then 71 ml of aqueous 3-n hydrochloric acid and 23 ml of concentrated aqueous hydrochloric acid are added under ice-cooling and extracted twice each time with 500 ml of acetic acid ethyl ester. The acetic ester extracts are washed in sequence twice with 200 ml of 2-n hydrochloric acid, twice with 200 ml of water and twice with 200 ml of a saturated, aqueous sodium bicarbonate solution, then combined, dried over sodium sulfate and evaporated under reduced pressure. The remaining [3,5-dibenzoyloxy-4-methoxy-phenyl]-acetone melts after two recrystallizations from ether at 88 - 89°C. 10 g of L3,5-dibenzoyloxy-4-methoxy-phenylj-acetone are dissolved in 100 ml of dioxane and hydrated after the addition of 20 ml of a saturated, aqueous ammonia solution using Raney nickel under normal conditions. The catalyst is filtered off after completion of hydrogen uptake. The filtrate is concentrated at 30°C under reduced pressure to approx. 50 ml, dilute with 50 ml of water and then extract twice each time with 100 ml of ethyl acetate. The acetic ester extracts are washed with 100 ml of water, combined, dried over sodium sulphate and evaporated under reduced pressure. The remainder is taken up in 10 ml of water. The insoluble parts are filtered off. 50 ml of ethereal hydrochloric acid is added to the filtrate. The precipitated oil-like 3,5-dibenzoyloxy-4-methoxy<y>-oc-methyl-phenethylamine hydrochloride crystallizes after digestion with acetonitrile and melts after repeated recrystallization from acetone/ether at 127 - 128°C.
EKSEMPEL 7 EXAMPLE 7
3,89 g 3,4-dibenzyloksy-5-metoksy-a-metyl-fenetylamin-hydroklorid innfores i 200 ml absolutt metanol og hydreres ved hjelp av 0,5 g palladiumkull [5 %\ under normalbetingelser. Hydreringen kommer til stil-lstand etter opptagelsen .av ca. 430 ml hydrogen. Katalysatoren filtreres fra. Filtratet inndampes. Det tilbakeblivende 3 ,4-dlhydroksy-5 -metok s y-oc-metyl - f enetylamin-hydrok lorid krystalliserer etter digerering med diisopropyleter. Forbindelsen smelter etter omkrystallisasjon fra metanol ved 270°C [spaltning]. 3.89 g of 3,4-dibenzyloxy-5-methoxy-a-methyl-phenethylamine hydrochloride are introduced into 200 ml of absolute methanol and hydrated with the aid of 0.5 g of palladium charcoal [5%] under normal conditions. The hydration comes to a standstill after the absorption of approx. 430 ml of hydrogen. The catalyst is filtered off. The filtrate is evaporated. The remaining 3,4-dlhydroxy-5-methoxy-oc-methyl-phenethylamine hydrochloride crystallizes after digestion with diisopropyl ether. The compound melts after recrystallization from methanol at 270°C [decomposition].
Det som utgangsforbindelse anvendte 3,4-dibenzyIoksy-5-metoksy-oc-metyl-f enetylamin-hydroklorid kan f. eks. fremstilles som folger: The 3,4-dibenzyloxy-5-methoxy-oc-methyl-phenethylamine hydrochloride used as starting compound can e.g. produced as follows:
E KSEMPEL 8 EXAMPLE 8
4,79 g 3,4,5-tribenzyloksy-a-metyl-fenetylamin-hydrobromid innfores i 200 ml absolutt metanol og hydreres ved hjelp av 0,5 g palladiumkull [5 %] under normalbetingelser. Hydreringen stopper etter opptagelsen av ca. 700 ml hydrogen. Katalysatoren filtreres fra. Filtratet inndampes. Det gjenværende 3,4,5-trihydroksy-a-metyl-fenetylamin-hydrobromid stiv-ner, som meget hygroskopisk skum som i luft straks flyter ut. 4.79 g of 3,4,5-tribenzyloxy-a-methyl-phenethylamine hydrobromide are introduced into 200 ml of absolute methanol and hydrated with the aid of 0.5 g of palladium charcoal [5%] under normal conditions. The hydration stops after the absorption of approx. 700 ml of hydrogen. The catalyst is filtered off. The filtrate is evaporated. The remaining 3,4,5-trihydroxy-a-methyl-phenethylamine hydrobromide solidifies as a very hygroscopic foam which immediately floats out in air.
Det som utgangsforbindelse anvendte 3,4,5-tribenzyloksy-a-metyl-fenetylamin-hydrobromid kan f.eks. fremstilles som folger: 42,4 g 3,4,5-tribenzyloksy-benzaldehyd og 15,0 g nitroetan oppvarmes sammen med en blanding av 2,6 ml n-butylamin og 4,5 ml iseddik i 120 ml vannfri toluen 12 timer under tilbake-lopsbetingelser. Det frigjorte vann oppfanges i en vannfra-skiller. Reaksjonsblandingen inndampes derpå under redusert trykk. Den tilbakeblivende olje renses ved adsorpsjon på silisiumgel. The 3,4,5-tribenzyloxy-α-methyl-phenethylamine hydrobromide used as starting compound can, for example, is prepared as follows: 42.4 g of 3,4,5-tribenzyloxy-benzaldehyde and 15.0 g of nitroethane are heated together with a mixture of 2.6 ml of n-butylamine and 4.5 ml of glacial acetic acid in 120 ml of anhydrous toluene for 12 hours under return-run conditions. The released water is collected in a water separator. The reaction mixture is then evaporated under reduced pressure. The remaining oil is purified by adsorption on silicon gel.
<c>,2 g litiumaluminiumhydrid innfores i 200 ml absolutt tetrahydrofuran og tilsettes i en argon-atmosfære dråpevis en opp-losning av 27,4 g 31,41,5'-tribenzyloksy-2-nitropropenyl-benzen i 200 ml absolutt tetrahydrofuran. Temperaturen for reaksjonsblandingen steg da til 55°C. Reaksjonsblandingen rores om ytterligere 7 timer ved 80°C, spaltes derpå etter 12 timers henstand ved værelsetemperatur forsiktig etter tilsetning av eddiksyreetylester med vann og oppvarmes kort til koking. Aluminiumoksydet som flokker seg ut, filtreres fra. Filtratet konsentreres og fordeles mellom eter og vann. Eter-fasen vaskes med vann, torkes og inndampes. Den gjenværende olje tilsettes 20 %'ig metanolisk bromhydrogensyre. Etter inndampning får man en svakt brun olje som straks viderefor-arbeides. <c>.2 g of lithium aluminum hydride is introduced into 200 ml of absolute tetrahydrofuran and a solution of 27.4 g of 31,41,5'-tribenzyloxy-2-nitropropenyl-benzene in 200 ml of absolute tetrahydrofuran is added dropwise in an argon atmosphere. The temperature of the reaction mixture then rose to 55°C. The reaction mixture is stirred for a further 7 hours at 80°C, then, after a 12-hour standstill at room temperature, is carefully decomposed after the addition of ethyl acetate with water and briefly heated to boiling. The aluminum oxide that flocculates is filtered off. The filtrate is concentrated and distributed between ether and water. The ether phase is washed with water, dried and evaporated. 20% methanolic hydrobromic acid is added to the remaining oil. After evaporation, a light brown oil is obtained, which is immediately further processed.
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH219668A CH500163A (en) | 1968-02-14 | 1968-02-14 | Process for the preparation of phenethylamine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NO122840B true NO122840B (en) | 1971-08-23 |
Family
ID=4228127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO0591/69A NO122840B (en) | 1968-02-14 | 1969-02-13 |
Country Status (13)
Country | Link |
---|---|
AT (2) | AT289061B (en) |
BE (1) | BE728327A (en) |
BR (1) | BR6906186D0 (en) |
CH (2) | CH500941A (en) |
DE (1) | DE1907247A1 (en) |
ES (1) | ES363591A1 (en) |
FR (1) | FR2011805A1 (en) |
GB (1) | GB1208231A (en) |
IE (1) | IE32946B1 (en) |
IL (1) | IL31513A (en) |
NL (1) | NL6901894A (en) |
NO (1) | NO122840B (en) |
SE (1) | SE367395B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3120419A1 (en) | 2021-03-07 | 2022-09-09 | Jean-Michel SCHULZ | Device with full control, management and steering authority for an on-board fuel or cryogenic fluid storage facility. |
FR3131359A1 (en) | 2021-12-28 | 2023-06-30 | Jean Michel SCHULZ | STRUCTURALLY OPTIMIZED LIGHTWEIGHT ONBOARD CRYOGENIC TANK |
FR3135253A1 (en) | 2022-05-09 | 2023-11-10 | Jean-Michel SCHULZ | Hydrogen storage and distribution device for aircraft. |
FR3136260A1 (en) | 2022-06-01 | 2023-12-08 | Jean Michel SCHULZ | Cryogenic pressurized hydrogen gas generator - cryogenic booster |
-
1968
- 1968-02-14 CH CH1734770A patent/CH500941A/en not_active IP Right Cessation
- 1968-02-14 CH CH219668A patent/CH500163A/en not_active IP Right Cessation
-
1969
- 1969-01-29 IL IL31513A patent/IL31513A/en unknown
- 1969-01-30 GB GB5181/69A patent/GB1208231A/en not_active Expired
- 1969-02-04 IE IE143/69A patent/IE32946B1/en unknown
- 1969-02-06 NL NL6901894A patent/NL6901894A/xx unknown
- 1969-02-07 BR BR206186/69A patent/BR6906186D0/en unknown
- 1969-02-13 AT AT147469A patent/AT289061B/en not_active IP Right Cessation
- 1969-02-13 ES ES363591A patent/ES363591A1/en not_active Expired
- 1969-02-13 DE DE19691907247 patent/DE1907247A1/en active Pending
- 1969-02-13 NO NO0591/69A patent/NO122840B/no unknown
- 1969-02-13 AT AT448170A patent/AT289757B/en not_active IP Right Cessation
- 1969-02-13 BE BE728327D patent/BE728327A/xx unknown
- 1969-02-13 FR FR6903428A patent/FR2011805A1/fr not_active Withdrawn
- 1969-02-14 SE SE02101/69A patent/SE367395B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL31513A0 (en) | 1969-03-27 |
SE367395B (en) | 1974-05-27 |
GB1208231A (en) | 1970-10-07 |
CH500163A (en) | 1970-12-15 |
ES363591A1 (en) | 1971-01-01 |
IE32946L (en) | 1969-08-14 |
DE1907247A1 (en) | 1969-09-18 |
BR6906186D0 (en) | 1973-01-16 |
AT289061B (en) | 1971-04-13 |
CH500941A (en) | 1970-12-31 |
NL6901894A (en) | 1969-08-18 |
IE32946B1 (en) | 1974-01-23 |
AT289757B (en) | 1971-05-10 |
BE728327A (en) | 1969-08-13 |
FR2011805A1 (en) | 1970-03-13 |
IL31513A (en) | 1972-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2507067A1 (en) | Sinomenine and sinomenine compounds, synthesis and use | |
PL163884B1 (en) | Method of obtaining fluoxetine and its additive acid salt | |
NO154116B (en) | PROCEDURE AND LAMEL PREPARATION DEVICE FOR SUPPLY AND DISTRIBUTION OF A COMPOSITION TO A LAMEL PREPARATION DEVICE. | |
NO166164B (en) | EQUIPMENT FOR AA ESTABLISH ELECTRICAL CONNECTION WITH A SINGLE SKIN ELECTRODE. | |
NO142865B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE CARBZOLS | |
NO120686B (en) | ||
DE1770595A1 (en) | Substituted tetrahydroquinolines | |
Corey et al. | The Synthesis of Dihydroconessine1 | |
Szmuszkovicz | 3-Acylindole mannich bases and their transformation products | |
NO122840B (en) | ||
NO773300L (en) | PROCEDURE FOR THE PREPARATION OF NEW acetic acid derivatives | |
NO143156B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NEW FOR THE TREATMENT OF EPILEPSY APPLICABLE DERIVATIVES OF 5H-DIBENZ (B, F) AZEPIN | |
US3255249A (en) | 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols | |
US2906757A (en) | Their preparation | |
US3932384A (en) | Dibenzazecines | |
US3070628A (en) | 4-allyloxybenzylamines | |
EP0070531B1 (en) | Tetrahydronaphthoxazoles | |
DE657526C (en) | Process for the preparation of esters of 9-Oxyfluorencarbonsaeure- (9) | |
US3209026A (en) | Cyclohexyloxycyclopropylamines | |
US2644817A (en) | 1-glycosido-5, 6 dimethyl benzimidazoles and process therefor | |
US3641097A (en) | Preparation of phenylalanine derivatives and novel intermediates | |
US2983736A (en) | Process for the preparation of 20-alkylamino steroid derivatives and novel 20-alkylamino steroid derivatives prepared thereby | |
CH619213A5 (en) | Process for the preparation of carbazole derivatives | |
NO771771L (en) | PROCEDURES FOR THE PREPARATION OF NEW DERIVATIVES OF DIBENZO (DE, H) QUINOLINE | |
US3189597A (en) | 3-glycosides of 17-amino-3-hydroxy-5-androstenes |